SELECTIVE D-1 DOPAMINE RECEPTOR INCREASE FOLLOWING CHRONIC TREATMENT WITH SCH 23390

被引:124
作者
CREESE, I
CHEN, A
机构
关键词
D O I
10.1016/0014-2999(85)90549-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:127 / 128
页数:2
相关论文
共 5 条
[1]   ANTI-SCHIZOPHRENIC DRUGS - CHRONIC TREATMENT ELEVATES DOPAMINE RECEPTOR-BINDING IN BRAIN [J].
BURT, DR ;
CREESE, I ;
SNYDER, SH .
SCIENCE, 1977, 196 (4287) :327-328
[2]   PHARMACOLOGICAL EFFECTS OF A SPECIFIC DOPAMINE D-1 ANTAGONIST SCH-23390 IN COMPARISON WITH NEUROLEPTICS [J].
CHRISTENSEN, AV ;
ARNT, J ;
HYTTEL, J ;
LARSEN, JJ ;
SVENDSEN, O .
LIFE SCIENCES, 1984, 34 (16) :1529-1540
[3]   CHANGES IN APOMORPHINE-INDUCED STEREOTYPY AS A RESULT OF SUBACUTE NEUROLEPTIC TREATMENT CORRELATES WITH INCREASED D-2 RECEPTORS, BUT NOT WITH INCREASES IN D-1 RECEPTORS [J].
FLEMINGER, S ;
RUPNIAK, NMJ ;
HALL, MD ;
JENNER, P ;
MARSDEN, CD .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (19) :2921-2927
[4]  
IORIO LC, 1983, J PHARMACOL EXP THER, V226, P462
[5]  
SEEMAN P, 1980, PHARMACOL REV, V32, P229